Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 4:17 AM
Ignite Modification Date: 2025-12-25 @ 4:17 AM
NCT ID: NCT03273920
Eligibility Criteria: Inclusion Criteria: 1. Pathologically proven gastric adenocarcinoma. 2. Tumor located in the lower third of the stomach, and is possible to be curatively resected by subtotal gastrectomy. 3. Preoperative stage of cT2-4aN0-3M0 according to American Joint Committee on Cancer/Union for International Cancer Control 8th edition 4. Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 5. American Society of Anesthesiology (ASA) score of class I to III 6. Patients who freely give informed consent to participate in the clinical study Exclusion Criteria: 1. Previous upper abdominal surgery (except laparoscopic cholecystectomy) 2. Previous gastric resection (gastrectomy, endoscopic mucosal resection, or endoscopic submucosal dissection) 3. Gastric cancer-related complications (complete obstruction or perforation) 4. Enlarged or bulky regional lymph node diameter larger than 3 cm based on preoperative imaging 5. Previous neoadjuvant chemotherapy or radiotherapy for gastric cancer 6. Patients diagnosed with other malignancy within 5 years 7. Severe mental disorder 8. Unstable angina or myocardial infarction within the past 6 months 9. Cerebrovascular accident within the past 6 months 10. Severe respiratory disease (FEV1\< 50%) 11. Continuous systemic steroid therapy within 1 month before the study 12. Pregnant or breast-feeding women
Healthy Volunteers: False
Sex: ALL
Minimum Age: 20 Years
Maximum Age: 75 Years
Study: NCT03273920
Study Brief:
Protocol Section: NCT03273920